Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Lin Gu"'
Autor:
Guan Xing, Shuo Ma, Nishan Rajakumaraswamy, Bianca Ruzicka, Rebecca J. Chan, Lin Gu, Nina D. Wagner-Johnston
Publikováno v:
Blood. 134:5468-5468
Introduction: Idelalisib (IDELA) is the first-in-class PI3Kδ inhibitor and is approved as a monotherapy for relapsed or refractory (R/R) follicular lymphoma and in combination with rituximab for R/R chronic lymphocytic leukemia (CLL). We previously